Q5117 Inj., kanjinti, 10 mg

Full Description

Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg

Code
Q5117
Short Description
Inj., kanjinti, 10 mg
Section
Q — Miscellaneous Services
Pricing Indicator
51
Source: CMS HCPCS October 2026 quarterly release.

Last reviewed: September 2026